
Annovis Bio Interview to Air on Bloomberg International on the RedChip Money Report
BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, announced an interview with CEO …
Read More